TickerStat.comwe like data

Medicenna Therapeutics Corp. (MDNAF)

Price$0.3460Cached quote
MDNAFOTC
Loading local price history

Financial charts

Total cash / debt

CashTotal debt

Financial statements

7 annual periodsNewest to oldest
2026202520242023202220212020
Revenue$0$0$0$0———
Research & development$16.9M$14.4M$10.8M$9.3M$14.7M$10.9M$5.9M
Operating expenses$22.4M$20.4M$18.7M$16.3M$22.5M$17.4M$8.2M
Operating income−$22.4M−$20.4M−$18.7M−$16.3M———
EBITDA−$22.3M−$20.4M−$18.7M−$16.3M———
Net income−$18.4M−$11.8M−$25.5M−$10.0M−$22.6M−$17.3M−$8.3M
Basic EPSper basic share-CA$0.22-CA$0.15-CA$0.37-CA$0.16-CA$0.42-CA$0.35-CA$0.26
Diluted EPSper diluted share-CA$0.22-CA$0.15-CA$0.37-CA$0.16—-CA$0.35-CA$0.26
Review official source filings ↗

Owners

Reported shareholders

Ownership data is not available for this listing yet.

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about MDNAF yet. Start the conversation.

Write the first post